AXA Framlington Biotech Fund - R Income

Category Sector Equity Biotechnology

Last buy/sell price

317.40p

arrow-up0.70p (+0.22%)

Fund Code

3100725

GB0031007254

Prices updated as at 12 Dec 2025

Prices in GBX

Investment objective

The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world, albeit the Fund tends to be biased towards the US as this is where the majority of biotechnology companies are based. The Manager selects shares based upon analysis of a company’s financial status, quality of its management, expected profitability and prospects for growth.

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , SDR Consumer facing disclosure, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual performance (%)

Year	This fund	Sector Equity Biotechnology
30 Sep 14 - 30 Sep 15	13.31	12.71
30 Sep 15 - 30 Sep 16	10.01	12.30
30 Sep 16 - 30 Sep 17	11.31	13.25
30 Sep 17 - 30 Sep 18	13.45	8.79
30 Sep 18 - 30 Sep 19	-17.91	-13.83
30 Sep 19 - 30 Sep 20	41.74	31.81
30 Sep 20 - 30 Sep 21	10.66	5.67
30 Sep 21 - 30 Sep 22	1.59	-16.37
30 Sep 22 - 30 Sep 23	-7.27	-9.58
30 Sep 23 - 30 Sep 24	10.89	5.94
30 Sep 24 - 30 Sep 25	-0.86	7.87

Trailing returns (%)

Year	This fund	Sector Equity Biotechnology
1 Day	0.22	0.52
1 Month	1.99	3.76
3 Months	18.70	23.65
6 Months	35.64	39.32
1 Year	15.46	23.88
3 Years annualised	7.61	9.88
5 Years annualised	5.35	3.99

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.